Author： Griffin J.P.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.14, Iss.3, 1998-09, pp. : 241-250
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Budget impacts and pharmacoeconomic evaluations
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 250, 2000-01 ,pp. :
Access to resources
Recommend
Accounting for Noncompliance in Pharmacoeconomic Evaluations
By Hughes D.A. Bagust A. Haycox A. Walley T.
PharmacoEconomics, Vol. 19, Iss. 12, 2001-01 ,pp. :
Reporting Pharmacoeconomic Evaluations
By Carswell C.I. Paladino J.A.
PharmacoEconomics, Vol. 23, Iss. 11, 2005-01 ,pp. :
The Role of Pharmacoeconomic Evaluations in Disease Management
PharmacoEconomics, Vol. 14, Iss. 1, 1998-07 ,pp. :
Interpreting pharmacoeconomic evaluations not an easy task
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 261, 2000-01 ,pp. :